Mexar join consortium for development of anti-microbial textile treatments

Mexar is delighted to announce its successful inclusion in the consortium group aimed at developing anti-microbial textile inks and treatments for the healthcare sector.

The so-called 'ACTIN' project is jointly funded between the UK and Mexican governments through Innovate UK.

“Mexar is extremely happy to be included in this fascinating area of technical textiles. Mexar’s involvement will be in the formulation of novel inkjet inks including nano-particles that have inherent anti-microbial properties,” explains Roger Tirrell, Commercial Director of Mexar. “We look forward to working on this project for the next two years and hope that it leads to a significant reduction in the spread of super bugs within the healthcare sector.”

Mexar and Valinge present new technology at IMI Europe Inkjet Conference

Mexar Ltd and Valinge Innovation are presenting at IMI Europe’s 2015 Inkjet Conference with a talk titled ‘Single pass printing of aqueous pigmented inks into powder substrates – a novel approach for the inkjet industry’.

Dr Andy Hancock of Mexar and Marcus Bergelin of Valinge will present the findings of a joint development project undertaken by the two companies.

“We are extremely excited to present at IMI Europe’s flagship event,” commented Andy Hancock. “It is a great forum to describe the technology we have created with Valinge and show it to the wider inkjet community.”

The IMI Europe conference runs from 2-4 December 2015 in Amsterdam. For more details see www.imieurope.com.